This browser does not support the video element.
A summary of the pharmacologic management of acute bleeding and secondary prevention of bleeds in LVAD patients. Supportive Measures Device Factors Octreotide Desmopressin Anti-secretory Agents (H2RA, PPI) Secondary Prevention: RAAS blockade Thalidomide Danazol Anticoagulation #LVAD #Bleeding #Pharmacology #Management #Treatment #Medications #Secondary #Prevention